Thursday, June 23, 2011
DIDA adds Paxil documents
We're pleased to announce the addition of 296 documents obtained by the Project on Government Oversight (POGO) from litigation about Paxil (paroxetine), an antidepressant manufactured by GlaxoSmithKline. POGO investigators found that NIH continues to fund academic researchers who use ghostwriters to write journal articles and other scientific communications.
POGO asked NIH to "implement new policies that will require institutions to ban ghostwriting, and to make NIH funding contingent upon periodic certification from institutions that ghostwriting is strictly prohibited and that enforcement mechanisms such as disciplinary action and dismissal are in place."
The documents can be found
here. And more information about the POGO investigation can be found
here.
Thursday, June 16, 2011
Medical Students Exposure to Drug Industry Marketing
PLoS Medicine article "
Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review" delves into medical student exposure to the pharmaceutical industry during their schooling and how this affects their attitudes towards the drug industry's marketing practices. Finds "undergraduate medical education provides substantial contact with pharmaceutical marketing, and the extent of such contact is associated with positive attitudes about marketing and skepticism about negative implications of these interactions."
@industrydocs on Twitter
Drug Industry RSS Feed
